Everything you need to need to know about the largest global startup funding rounds of Q1 2021; broken down by industry, stage, investors, and more…
Everything you need to need to know about the largest global startup funding rounds of March 2021; broken down by industry, stage, investors, and more…
$8.8B raised by NYC startups in Q1 in the single-best quarter in NYC history. Here are some of the leading startups that are scaling fast and attracting new capital.
$20.2B raised by US startups in March. Here’s a roundup of the largest funding rounds.
March 2021 was the single best month for NYC startup funding in history. These companies led the funding charge with 16 mega ($100M) rounds between them, raising $3.5B in aggregate during the month.
The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity in the various markets that we track. The notable startup funding rounds for the week ending 3/27/21 featuring funding details for Ginger, Ease, and twenty-five other rounds that you must know about.
The pandemic has shaped the future of remote healthcare as the importance of providing access to essential healthcare services grew dramatically as the world scrambled to move to digital. In fact, 23.6% of all healthcare interactions were via telehealth during the first four months of the pandemic, up from just .3% for the same period in 2019. Ro, founded in 2017, is one of the pioneering patient-driven telehealth companies that’s built to be the first point of contact when you need to see a physician. The technology allows you to seamlessly connect with a physician, nurse, or pharmacist in minutes instead of days or weeks, bringing the care experience online instead of at a doctor’s office. Ro also operates its own pharmacy fulfillment business, effectively allowing the company to support patient needs from the initial diagnosis to treatment/delivery and everything in between. Structured as a holding company that’s able to capitalize on a robust centralized platform, Ro operates a growing family of brands that redefine how we approach healthcare. Among them are Roman (digital health clinic for men), Rory (digital health for women), Zero (smoking cessation), Ro Pharmacy, Plenity (weight management), and Workpath (API to power on-demand, in-home healthcare). It’s safe to assume that the massive shift towards telehealth has provided Ro with valuable data on patient preferences that will fuel the company’s future verticals and next phase of expansion, armed with this latest round of funding.
AlleyWatch caught up with CEO and Cofounder Zachariah Reitano to learn more about the vision behind the business, how the rush to telehealth drives down healthcare costs, the company’s impressive traction, helping vaccinate New Yorkers, and Ro’s latest funding, which comes at a reported $5B valuation – 3x+ its valuation from its last round over the summer, and much, much more.